Tucker Asset Management LLC Obs Eva Sa Transaction History

Tucker Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.08 - $0.23 $23,863 - $68,607	-298,292 Closed	0 $0
Q3 2022 May 11, 2023	SELL	$0.14 - $1.83 $41,760 - $545,874	-298,292 Closed	0 $0
Q2 2022 May 11, 2023	BUY	$1.34 - $2.08 $399,711 - $620,447	298,292 New	298,292 $480 Million
Q1 2022 May 11, 2023	BUY	$1.1 - $2.17 $328,121 - $647,293	298,292 New	298,292 $450 Million

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Tucker Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tucker Asset Management LLC with notifications on news.